Global Androgen Deprivation Therapy (ADT) Sales Market Report 2016

Global Androgen Deprivation Therapy (ADT) Sales Market Report 2016

1 Androgen Deprivation Therapy (ADT) Overview

1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)

1.2 Classification of Androgen Deprivation Therapy (ADT)

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Androgen Deprivation Therapy (ADT)

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Androgen Deprivation Therapy (ADT) Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Androgen Deprivation Therapy (ADT) (2011-2021)

1.5.1 Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2021)

1.5.2 Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

2 Global Androgen Deprivation Therapy (ADT) Competition by Manufacturers, Type and Application

2.1 Global Androgen Deprivation Therapy (ADT) Market Competition by Manufacturers

2.1.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Androgen Deprivation Therapy (ADT) Revenue and Share by Manufacturers (2011-2016)

2.2 Global Androgen Deprivation Therapy (ADT) (Volume and Value) by Type

2.2.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Type (2011-2016)

2.2.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2011-2016)

2.3 Global Androgen Deprivation Therapy (ADT) (Volume and Value) by Regions

2.3.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Regions (2011-2016)

2.3.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Regions (2011-2016)

2.4 Global Androgen Deprivation Therapy (ADT) (Volume) by Application

3 USA Androgen Deprivation Therapy (ADT) (Volume, Value and Sales Price)

3.1 USA Androgen Deprivation Therapy (ADT) Sales and Value (2011-2016)

3.1.1 USA Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

3.1.2 USA Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

3.1.3 USA Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

3.2 USA Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers

3.3 USA Androgen Deprivation Therapy (ADT) Sales and Market Share by Type

3.4 USA Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

4 China Androgen Deprivation Therapy (ADT) (Volume, Value and Sales Price)

4.1 China Androgen Deprivation Therapy (ADT) Sales and Value (2011-2016)

4.1.1 China Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

4.1.2 China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

4.1.3 China Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

4.2 China Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers

4.3 China Androgen Deprivation Therapy (ADT) Sales and Market Share by Type

4.4 China Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

5 Europe Androgen Deprivation Therapy (ADT) (Volume, Value and Sales Price)

5.1 Europe Androgen Deprivation Therapy (ADT) Sales and Value (2011-2016)

5.1.1 Europe Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

5.1.2 Europe Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

5.1.3 Europe Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

5.2 Europe Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers

5.3 Europe Androgen Deprivation Therapy (ADT) Sales and Market Share by Type

5.4 Europe Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

6 Japan Androgen Deprivation Therapy (ADT) (Volume, Value and Sales Price)

6.1 Japan Androgen Deprivation Therapy (ADT) Sales and Value (2011-2016)

6.1.1 Japan Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

6.1.2 Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

6.1.3 Japan Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

6.2 Japan Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers

6.3 Japan Androgen Deprivation Therapy (ADT) Sales and Market Share by Type

6.4 Japan Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

7 India Androgen Deprivation Therapy (ADT) (Volume, Value and Sales Price)

7.1 India Androgen Deprivation Therapy (ADT) Sales and Value (2011-2016)

7.1.1 India Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

7.1.2 India Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

7.1.3 India Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

7.2 India Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers

7.3 India Androgen Deprivation Therapy (ADT) Sales and Market Share by Type

7.4 India Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

8 Southeast Asia Androgen Deprivation Therapy (ADT) (Volume, Value and Sales Price)

8.1 Southeast Asia Androgen Deprivation Therapy (ADT) Sales and Value (2011-2016)

8.1.1 Southeast Asia Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

8.2 Southeast Asia Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers

8.3 Southeast Asia Androgen Deprivation Therapy (ADT) Sales and Market Share by Type

8.4 Southeast Asia Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

9 Global Androgen Deprivation Therapy (ADT) Manufacturers Analysis

9.1 Pfizer Inc. (USA)

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Abbott Laboratories (USA)

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 127 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Genentech Inc. (USA)

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 141 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 GlaxoSmithKline Plc (UK)

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Immunomedics, Inc. (USA)

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Indevus Pharmaceuticals Inc. (USA)

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Novartis AG (Switzerland)

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 OSI Pharmaceuticals, Inc. (USA)

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Paladin Labs Inc. (Canada)

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 ALZA Corporation (USA)

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Amgen Inc. (USA)

9.12 AstraZeneca PLC (UK)

9.13 Medimmune, LLC (USA)

9.14 Bristol-Myers Squibb Company (USA)

9.15 Cell Genesys Inc. (USA)

9.16 Dendreon Corporation (USA)

9.17 EUSA Pharma, (USA) Inc. (USA)

9.18 F. Hoffmann-La Roche Ltd. (Switzerland)

9.19 Progenics Pharmaceuticals, Inc. (USA)

9.20 Sanofi-Aventis SA (France)

9.21 Spectrum Pharmaceuticals, Inc. (USA)

9.22 Takeda Pharmaceutical Company Limited (Japan)

10 Androgen Deprivation Therapy (ADT) Maufacturing Cost Analysis

10.1 Androgen Deprivation Therapy (ADT) Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Androgen Deprivation Therapy (ADT) Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Androgen Deprivation Therapy (ADT) Market Forecast (2016-2021)

14.1 Global Androgen Deprivation Therapy (ADT) Sales, Revenue Forecast (2016-2021)

14.2 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Regions (2016-2021)

14.3 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Type (2016-2021)

14.4 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Androgen Deprivation Therapy (ADT)

Table Classification of Androgen Deprivation Therapy (ADT)

Figure Global Sales Market Share of Androgen Deprivation Therapy (ADT) by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Androgen Deprivation Therapy (ADT)

Figure Global Sales Market Share of Androgen Deprivation Therapy (ADT) by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

Figure China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

Figure Europe Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

Figure Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

Figure India Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

Figure Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2021)

Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

Table Global Androgen Deprivation Therapy (ADT) Sales of Key Manufacturers (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers (2011-2016)

Figure 2015 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers

Figure 2016 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers

Table Global Androgen Deprivation Therapy (ADT) Revenue by Manufacturers (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers

Table 2016 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers

Table Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Type (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Sales Share by Type (2011-2016)

Figure Sales Market Share of Androgen Deprivation Therapy (ADT) by Type (2011-2016)

Figure Global Androgen Deprivation Therapy (ADT) Sales Growth Rate by Type (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Androgen Deprivation Therapy (ADT) by Type (2011-2016)

Figure Global Androgen Deprivation Therapy (ADT) Revenue Growth Rate by Type (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Regions (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Sales Share by Regions (2011-2016)

Figure Sales Market Share of Androgen Deprivation Therapy (ADT) by Regions (2011-2016)

Figure Global Androgen Deprivation Therapy (ADT) Sales Growth Rate by Regions (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Regions (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Androgen Deprivation Therapy (ADT) by Regions (2011-2016)

Figure Global Androgen Deprivation Therapy (ADT) Revenue Growth Rate by Regions (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Application (2011-2016)

Table Global Androgen Deprivation Therapy (ADT) Sales Share by Application (2011-2016)

Figure Sales Market Share of Androgen Deprivation Therapy (ADT) by Application (2011-2016)

Figure Global Androgen Deprivation Therapy (ADT) Sales Growth Rate by Application (2011-2016)

Figure USA Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

Figure USA Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

Figure USA Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

Table USA Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2011-2016)

Table USA Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2011-2016)

Table USA Androgen Deprivation Therapy (ADT) Sales by Type (2011-2016)

Table USA Androgen Deprivation Therapy (ADT) Market Share by Type (2011-2016)

Table USA Androgen Deprivation Therapy (ADT) Sales by Application (2011-2016)

Table USA Androgen Deprivation Therapy (ADT) Market Share by Application (2011-2016)

Figure China Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

Figure China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

Figure China Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

Table China Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2011-2016)

Table China Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2011-2016)

Table China Androgen Deprivation Therapy (ADT) Sales by Type (2011-2016)

Table China Androgen Deprivation Therapy (ADT) Market Share by Type (2011-2016)

Table China Androgen Deprivation Therapy (ADT) Sales by Application (2011-2016)

Table China Androgen Deprivation Therapy (ADT) Market Share by Application (2011-2016)

Figure Europe Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

Figure Europe Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

Figure Europe Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

Table Europe Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2011-2016)

Table Europe Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2011-2016)

Table Europe Androgen Deprivation Therapy (ADT) Sales by Type (2011-2016)

Table Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2011-2016)

Table Europe Androgen Deprivation Therapy (ADT) Sales by Application (2011-2016)

Table Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2011-2016)

Figure Japan Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

Figure Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

Figure Japan Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

Table Japan Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2011-2016)

Table Japan Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2011-2016)

Table Japan Androgen Deprivation Therapy (ADT) Sales by Type (2011-2016)

Table Japan Androgen Deprivation Therapy (ADT) Market Share by Type (2011-2016)

Table Japan Androgen Deprivation Therapy (ADT) Sales by Application (2011-2016)

Table Japan Androgen Deprivation Therapy (ADT) Market Share by Application (2011-2016)

Figure India Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

Figure India Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

Figure India Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

Table India Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2011-2016)

Table India Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2011-2016)

Table India Androgen Deprivation Therapy (ADT) Sales by Type (2011-2016)

Table India Androgen Deprivation Therapy (ADT) Market Share by Type (2011-2016)

Table India Androgen Deprivation Therapy (ADT) Sales by Application (2011-2016)

Table India Androgen Deprivation Therapy (ADT) Market Share by Application (2011-2016)

Figure Southeast Asia Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2016)

Figure Southeast Asia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Androgen Deprivation Therapy (ADT) Sales Price Trend (2011-2016)

Table Southeast Asia Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2011-2016)

Table Southeast Asia Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2011-2016)

Table Southeast Asia Androgen Deprivation Therapy (ADT) Sales by Type (2011-2016)

Table Southeast Asia Androgen Deprivation Therapy (ADT) Market Share by Type (2011-2016)

Table Southeast Asia Androgen Deprivation Therapy (ADT) Sales by Application (2011-2016)

Table Southeast Asia Androgen Deprivation Therapy (ADT) Market Share by Application (2011-2016)

Table Pfizer Inc. (USA) Basic Information List

Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information List

Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Genentech Inc. (USA) Basic Information List

Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information List

Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Immunomedics, Inc. (USA) Basic Information List

Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Indevus Pharmaceuticals Inc. (USA) Basic Information List

Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Novartis AG (Switzerland) Basic Information List

Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table OSI Pharmaceuticals, Inc. (USA) Basic Information List

Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Paladin Labs Inc. (Canada) Basic Information List

Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table ALZA Corporation (USA) Basic Information List

Table ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Amgen Inc. (USA) Basic Information List

Table Amgen Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table AstraZeneca PLC (UK) Basic Information List

Table AstraZeneca PLC (UK) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AstraZeneca PLC (UK) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Medimmune, LLC (USA) Basic Information List

Table Medimmune, LLC (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Medimmune, LLC (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Bristol-Myers Squibb Company (USA) Basic Information List

Table Bristol-Myers Squibb Company (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb Company (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Cell Genesys Inc. (USA) Basic Information List

Table Cell Genesys Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cell Genesys Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Dendreon Corporation (USA) Basic Information List

Table Dendreon Corporation (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Dendreon Corporation (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table EUSA Pharma, (USA) Inc. (USA) Basic Information List

Table EUSA Pharma, (USA) Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure EUSA Pharma, (USA) Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure F. Hoffmann-La Roche Ltd. (Switzerland) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List

Table Progenics Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Progenics Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Sanofi-Aventis SA (France) Basic Information List

Table Sanofi-Aventis SA (France) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi-Aventis SA (France) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List

Table Spectrum Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Spectrum Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List

Table Takeda Pharmaceutical Company Limited (Japan) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Takeda Pharmaceutical Company Limited (Japan) Androgen Deprivation Therapy (ADT) Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Androgen Deprivation Therapy (ADT)

Figure Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)

Figure Androgen Deprivation Therapy (ADT) Industrial Chain Analysis

Table Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2015

Table Major Buyers of Androgen Deprivation Therapy (ADT)

Table Distributors/Traders List

Figure Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate Forecast (2016-2021)

Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate Forecast (2016-2021)

Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Regions (2016-2021)

Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Type (2016-2021)

Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Application (2016-2021)